Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) FCF Margin (2017 - 2025)

Inspire Medical Systems' FCF Margin history spans 9 years, with the latest figure at 15.54% for Q4 2025.

  • For Q4 2025, FCF Margin fell 1039.0% year-over-year to 15.54%; the TTM value through Dec 2025 reached 8.61%, down 275.0%, while the annual FY2025 figure was 8.61%, 275.0% down from the prior year.
  • FCF Margin for Q4 2025 was 15.54% at Inspire Medical Systems, down from 20.7% in the prior quarter.
  • Across five years, FCF Margin topped out at 25.93% in Q4 2024 and bottomed at 28.77% in Q1 2021.
  • The 5-year median for FCF Margin is 2.14% (2025), against an average of 0.86%.
  • The largest annual shift saw FCF Margin skyrocketed 18794bps in 2021 before it tumbled -1039bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 1.42% in 2021, then soared by 486bps to 8.34% in 2022, then plummeted by -118bps to 1.49% in 2023, then skyrocketed by 1843bps to 25.93% in 2024, then plummeted by -40bps to 15.54% in 2025.
  • Per Business Quant, the three most recent readings for INSP's FCF Margin are 15.54% (Q4 2025), 20.7% (Q3 2025), and 2.44% (Q2 2025).